Impact of the New EMA Guideline on the Environmental Risk Assessment of Human Pharmaceuticals Webinar

Webinar_ Impact of the New EMA Guideline on the Environmental Risk Assessment of Human Pharmaceuticals-low-1

This webinar explores the impact of the revised Pharmaceutical Environmental Risk Assessment (pERA) guidance and the upcoming changes to EU pharmaceuticals legislation. Hear from experts at Fera and Regulatory Science Associates as they delve into:

  • Key updates to pERA requirements
  • What the new EU legislation means for your regulatory strategy
  • How eFate and ecotoxicology data shape compliant submissions
  • How to integrate pERA considerations effectively into the early stages of product development.

Speakers

Glyn Horner
Head of Growth Chemical Services, Fera Science Ltd.

Richard Murray-Smith
Consultant, Environmental Risk Assessment, Regulatory Science Associates Ltd.

Ainsley Jones
Science Lead - Chemical Safety, Fera Science Ltd.

Karen Thorpe
Senior Aquatic Ecotoxicologist, Fera Science Ltd.

Find out more about our services

Pharmaceuticals in the Environment

Fill out the form to view the recording

Fera Science Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.